Inhibitors of the enzyme phospholipase D1 suppress the replication of HIV-1, Vanderbilt investigators have discovered.

Vanderbilt University researchers have come closer to solving a mystery that has puzzled scientists for more than a century: after the loss of one kidney, what causes the growth of the remaining kidney to take up the slack?

Unstable federal research funding and reductions in health care revenue for academic medical centers threatens to undermine the nation’s biomedical research enterprise, and in turn clinical medicine, which the nation needs now more than ever.

The financial reorganization and separation of Vanderbilt University and Vanderbilt University Medical Center into separate nonprofit entities remains on schedule to occur in early 2016.

With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.

National Institutes of Health Director Francis Collins, M.D., Ph.D., will deliver a special Discovery Lecture at Vanderbilt University Medical Center next Thursday, May 28.